NYSE:TFX Teleflex (TFX) Stock Forecast, Price & News $236.47 +2.70 (+1.15%) (As of 05:11 PM ET) Add Compare Share Share Today's Range$233.43▼$236.5950-Day Range$232.06▼$274.1152-Week Range$182.65▼$289.24Volume317,630 shsAverage Volume316,262 shsMarket Capitalization$11.09 billionP/E Ratio30.83Dividend Yield0.58%Price Target$273.38 ProfileProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Teleflex MarketRank™ ForecastAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside15.6% Upside$273.38 Price TargetShort InterestBearish3.58% of Shares Sold ShortDividend StrengthWeakBased on Four FactorsSustainability-1.53Upright™ Environmental ScoreNews Sentiment0.76Based on 11 Articles This WeekInsider TradingSelling Shares$742,290 Sold Last QuarterProj. Earnings Growth9.41%From $13.29 to $14.54 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.50 out of 5 starsMedical Sector129th out of 983 stocksSurgical & Medical Instruments Industry14th out of 98 stocks 2.3 Analyst's Opinion Consensus RatingTeleflex has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 6 buy ratings, 6 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $273.38, Teleflex has a forecasted upside of 15.6% from its current price of $236.47.Amount of Analyst CoverageTeleflex has only been the subject of 4 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted3.58% of the outstanding shares of Teleflex have been sold short.Short Interest Ratio / Days to CoverTeleflex has a short interest ratio ("days to cover") of 5.1.Change versus previous monthShort interest in Teleflex has recently increased by 11.26%, indicating that investor sentiment is decreasing significantly. Previous Next 1.7 Dividend Strength Dividend YieldTeleflex has a dividend yield of 0.58%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthTeleflex does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Teleflex is 17.73%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Teleflex will have a dividend payout ratio of 9.35% next year. This indicates that Teleflex will be able to sustain or increase its dividend. Previous Next 3.9 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreTeleflex has received a 53.08% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Wound closure devices", "Surgical clamps", and "Catheters" products. See details.Environmental SustainabilityThe Environmental Impact score for Teleflex is -1.53. Previous Next 3.2 News and Social Media Coverage News SentimentTeleflex has a news sentiment score of 0.76. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.52 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 11 news articles for Teleflex this week, compared to 5 articles on an average week.Search InterestOnly 2 people have searched for TFX on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat Follows3 people have added Teleflex to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Teleflex insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $742,290.00 in company stock.Percentage Held by InsidersOnly 1.41% of the stock of Teleflex is held by insiders.Percentage Held by Institutions93.82% of the stock of Teleflex is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Teleflex are expected to grow by 9.41% in the coming year, from $13.29 to $14.54 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Teleflex is 30.83, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 126.53.Price to Earnings Ratio vs. SectorThe P/E ratio of Teleflex is 30.83, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 101.10.Price to Earnings Growth RatioTeleflex has a PEG Ratio of 2.50. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioTeleflex has a P/B Ratio of 2.70. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Teleflex (NYSE:TFX) StockTeleflex, Inc. provides medical technology products which enables healthcare providers to improve patient outcomes and enhance patient and provider safety. The firm designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates through the following business segments: Americas, EMEA (Europe, the Middle East and Africa), Asia (Asia Pacific) and OEM. The Americas segment engages in the sales of interventional urology products. The EMEA engages in the sales of urology products. The Asia segment designs, manufactures and distributes medical devices primarily used in critical care, surgical applications and cardiac care and generally serves hospitals and healthcare providers. The OEM segment designs, manufactures and supplies devices and instruments for other medical device manufacturers. The company was founded in 1943 and is headquartered in Wayne, PA.Read More Receive TFX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Teleflex and its competitors with MarketBeat's FREE daily newsletter. Email Address TFX Stock News HeadlinesJune 2, 2023 | americanbankingnews.comTeleflex Incorporated (NYSE:TFX) Receives $269.18 Consensus Target Price from AnalystsJune 1, 2023 | msn.comPremier signs purchasing agreement with TeleflexJune 2, 2023 | Edge On The Street (Ad)The Real Problem With "Made in America" LithiumPoliticians love to say they support "Made in America" when it comes to manufacturing. But when it comes to lithium - the metal fueling our transition to electric vehicles - it's not that simple. June 1, 2023 | americanbankingnews.comTeleflex (NYSE:TFX) Coverage Initiated at CL KingMay 31, 2023 | msn.comCL King Initiates Coverage of Teleflex (TFX) with Buy RecommendationMay 30, 2023 | msn.comExpert Ratings for TeleflexMay 18, 2023 | americanbankingnews.comStockNews.com Begins Coverage on Teleflex (NYSE:TFX)May 16, 2023 | msn.comTeleflex's Return on Invested Capital InsightsJune 2, 2023 | Edge On The Street (Ad)The Real Problem With "Made in America" LithiumPoliticians love to say they support "Made in America" when it comes to manufacturing. But when it comes to lithium - the metal fueling our transition to electric vehicles - it's not that simple. May 15, 2023 | finance.yahoo.comTeleflex Publishes 2022 Global Impact ReportMay 13, 2023 | americanbankingnews.comStuart A. Randle Sells 3,021 Shares of Teleflex Incorporated (NYSE:TFX) StockMay 11, 2023 | americanbankingnews.comTeleflex (NYSE:TFX) Upgraded at StockNews.comMay 10, 2023 | marketwatch.comTeleflex Inc. stock falls Wednesday, underperforms marketMay 10, 2023 | marketwatch.comTeleflex Inc. stock outperforms competitors on strong trading dayMay 10, 2023 | msn.comRaymond James Maintains Teleflex (TFX) Outperform RecommendationMay 10, 2023 | msn.comTeleflex (TFX) Declares $0.34 DividendMay 9, 2023 | finance.yahoo.comAn Intrinsic Calculation For Teleflex Incorporated (NYSE:TFX) Suggests It's 20% UndervaluedMay 9, 2023 | americanbankingnews.comTeleflex Incorporated to Post Q2 2023 Earnings of $3.15 Per Share, KeyCorp Forecasts (NYSE:TFX)May 8, 2023 | americanbankingnews.comBrokerages Set Teleflex Incorporated (NYSE:TFX) Target Price at $273.00May 6, 2023 | seekingalpha.comTeleflex Incorporated 2023 Q1 - Results - Earnings Call PresentationMay 4, 2023 | finance.yahoo.comTeleflex (TFX) Reports Q1 Earnings: What Key Metrics Have to SayMay 4, 2023 | finance.yahoo.comTeleflex Reports First Quarter Financial Results and Full Year 2023 OutlookMay 3, 2023 | finance.yahoo.comNew Data Highlight that Early Intervention with the UroLift® System Facilitates Long-Term Outcomes for BPH PatientsMay 2, 2023 | finance.yahoo.comDo You Think Teleflex Incorporated (TFX) is Facing Tougher Competition?May 2, 2023 | finance.yahoo.comTeleflex Launches New Arrow® VPS Rhythm® DLX Device and NaviCurve™ Stylet in the United StatesApril 26, 2023 | americanbankingnews.comTeleflex (NYSE:TFX) Lowered to "Market Perform" at Wolfe ResearchApril 25, 2023 | finance.yahoo.comTeleflex to Present at the Bank of America Securities 2023 Health Care ConferenceSee More Headlines TFX Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TFX Company Calendar Ex-Dividend for 3/15 Dividend3/02/2023Dividend Payable3/15/2023Last Earnings5/04/2023Ex-Dividend for 6/15 Dividend5/12/2023Today6/02/2023Dividend Payable6/15/2023Next Earnings (Estimated)7/27/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Surgical & medical instruments Sub-IndustryHealth Care Equipment SectorMedical Current SymbolNYSE:TFX CUSIP87936910 CIK96943 Webwww.teleflex.com Phone(610) 225-6800Fax215-553-5402Employees15,500Year Founded1943Price Target and Rating Average Stock Price Forecast$273.38 High Stock Price Forecast$330.00 Low Stock Price Forecast$210.00 Forecasted Upside/Downside+16.9%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage12 Analysts Profitability EPS (Most Recent Fiscal Year)$7.67 Trailing P/E Ratio30.48 Forward P/E Ratio17.59 P/E Growth2.5Net Income$363.14 million Net Margins12.68% Pretax Margin15.73% Return on Equity15.80% Return on Assets9.18% Debt Debt-to-Equity Ratio0.38 Current Ratio2.48 Quick Ratio1.41 Sales & Book Value Annual Sales$2.79 billion Price / Sales3.93 Cash Flow$18.09 per share Price / Cash Flow12.92 Book Value$87.64 per share Price / Book2.67Miscellaneous Outstanding Shares46,900,000Free Float46,239,000Market Cap$10.96 billion OptionableOptionable Beta1.00 Social Links Key ExecutivesLiam J. KellyChairman, President & Chief Executive OfficerThomas E. PowellChief Financial Officer & Executive Vice PresidentJustin McMurrayVP-Global Strategic Research & DevelopmentTimothy F. DuffyChief Information Officer & Vice PresidentMichelle FoxChief Medical Officer & Vice PresidentKey CompetitorsGlobus MedicalNYSE:GMEDIntegra LifeSciencesNASDAQ:IARTInsuletNASDAQ:PODDBaxter InternationalNYSE:BAXResMedNYSE:RMDView All CompetitorsInsiders & InstitutionsProShare Advisors LLCBought 863 shares on 5/26/2023Ownership: 0.021%Mountain Pacific Investment Advisers Inc. IDSold 1,163 shares on 5/23/2023Ownership: 0.168%Toroso Investments LLCSold 55 shares on 5/23/2023Ownership: 0.002%Ameriprise Financial Inc.Sold 6,646 shares on 5/22/2023Ownership: 0.029%New York State Common Retirement FundSold 5,205 shares on 5/18/2023Ownership: 0.105%View All Insider TransactionsView All Institutional Transactions TFX Stock - Frequently Asked Questions Should I buy or sell Teleflex stock right now? 12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Teleflex in the last twelve months. There are currently 6 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" TFX shares. View TFX analyst ratings or view top-rated stocks. What is Teleflex's stock price forecast for 2023? 12 brokerages have issued twelve-month price objectives for Teleflex's stock. Their TFX share price forecasts range from $210.00 to $330.00. On average, they anticipate the company's stock price to reach $273.38 in the next twelve months. This suggests a possible upside of 16.9% from the stock's current price. View analysts price targets for TFX or view top-rated stocks among Wall Street analysts. How have TFX shares performed in 2023? Teleflex's stock was trading at $249.63 at the start of the year. Since then, TFX shares have decreased by 6.4% and is now trading at $233.77. View the best growth stocks for 2023 here. When is Teleflex's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, July 27th 2023. View our TFX earnings forecast. How were Teleflex's earnings last quarter? Teleflex Incorporated (NYSE:TFX) released its earnings results on Thursday, May, 4th. The medical technology company reported $3.09 EPS for the quarter, topping analysts' consensus estimates of $2.97 by $0.12. The medical technology company earned $710.90 million during the quarter, compared to analysts' expectations of $687.11 million. Teleflex had a trailing twelve-month return on equity of 15.80% and a net margin of 12.68%. The company's revenue for the quarter was up 10.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.88 EPS. Read the conference call transcript. How often does Teleflex pay dividends? What is the dividend yield for Teleflex? Teleflex announced a quarterly dividend on Monday, May 8th. Stockholders of record on Monday, May 15th will be given a dividend of $0.34 per share on Thursday, June 15th. This represents a $1.36 annualized dividend and a dividend yield of 0.58%. The ex-dividend date is Friday, May 12th. Read our dividend analysis for TFX. What ETFs hold Teleflex's stock? ETFs with the largest weight of Teleflex (NYSE:TFX) stock in their portfolio include First Trust Indxx Medical Devices ETF (MDEV), Invesco S&P 500 Equal Weight Health Care ETF (RYH), SPDR S&P Health Care Equipment ETF (XHE), iShares U.S. Medical Devices ETF (IHI), Mid Cap US Equity Select ETF (RNMC), Global X Aging Population ETF (AGNG), First Trust Health Care AlphaDEX Fund (FXH) and Timothy Plan US Large Cap Core ETF (TPLC). Is Teleflex a good dividend stock? Teleflex (NYSE:TFX) pays an annual dividend of $1.36 per share and currently has a dividend yield of 0.58%. The dividend payout ratio is 17.73%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, TFX will have a dividend payout ratio of 9.35% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for TFX. What guidance has Teleflex issued on next quarter's earnings? Teleflex issued an update on its FY 2023 earnings guidance on Thursday, May, 4th. The company provided earnings per share guidance of $13.00-$13.60 for the period, compared to the consensus estimate of $13.29. The company issued revenue guidance of $2.92 billion-$2.96 billion, compared to the consensus revenue estimate of $2.93 billion. What is Liam Kelly's approval rating as Teleflex's CEO? 73 employees have rated Teleflex Chief Executive Officer Liam Kelly on Glassdoor.com. Liam Kelly has an approval rating of 86% among the company's employees. What other stocks do shareholders of Teleflex own? Based on aggregate information from My MarketBeat watchlists, some companies that other Teleflex investors own include NVIDIA (NVDA), AbbVie (ABBV), Johnson & Johnson (JNJ), Alibaba Group (BABA), Lam Research (LRCX), ServiceNow (NOW), QUALCOMM (QCOM), Advanced Micro Devices (AMD), Salesforce (CRM) and Cisco Systems (CSCO). What is Teleflex's stock symbol? Teleflex trades on the New York Stock Exchange (NYSE) under the ticker symbol "TFX." Who are Teleflex's major shareholders? Teleflex's stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (8.48%), Wellington Management Group LLP (6.60%), State Street Corp (4.96%), Price T Rowe Associates Inc. MD (3.90%), Geode Capital Management LLC (2.07%) and Allspring Global Investments Holdings LLC (1.80%). Insiders that own company stock include Andrew A Krakauer, Cameron P Hicks, Liam Kelly, Stephen K MD Klasko, Stephen K MD Klasko and Stuart A Randle. View institutional ownership trends. How do I buy shares of Teleflex? Shares of TFX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Teleflex's stock price today? One share of TFX stock can currently be purchased for approximately $233.77. How much money does Teleflex make? Teleflex (NYSE:TFX) has a market capitalization of $10.96 billion and generates $2.79 billion in revenue each year. The medical technology company earns $363.14 million in net income (profit) each year or $7.67 on an earnings per share basis. How many employees does Teleflex have? The company employs 15,500 workers across the globe. How can I contact Teleflex? Teleflex's mailing address is 550 E SWEDESFORD RD, WAYNE PA, 19087. The official website for the company is www.teleflex.com. The medical technology company can be reached via phone at (610) 225-6800, via email at shareholder@broadridge.com, or via fax at 215-553-5402. This page (NYSE:TFX) was last updated on 6/2/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Teleflex Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.